

Can't fill your Envarsus XR prescription? Learn about alternative immunosuppressants for transplant patients, including Prograf.
If you're a kidney transplant patient and your pharmacy can't fill your Envarsus XR prescription, your mind probably goes to a dark place fast. Immunosuppressant medications aren't optional — they're what keep your body from rejecting your transplanted kidney.
The first thing to know: never stop taking your immunosuppressant or skip doses without talking to your transplant team. The second thing: there are alternatives to Envarsus XR, but switching must always be done under medical supervision. Let's walk through what's available.
Envarsus XR contains Tacrolimus, a calcineurin inhibitor that suppresses the immune system to prevent organ rejection. It works by blocking calcineurin, a protein that activates T cells — the white blood cells that would otherwise attack your transplanted kidney as a foreign object.
What makes Envarsus XR unique is its MeltDose® extended-release technology, which allows the medication to be taken just once daily instead of twice daily like traditional Tacrolimus capsules. This formulation provides more consistent drug levels throughout the day, which can mean better outcomes and fewer side effects for some patients.
Envarsus XR comes in 0.75 mg, 1 mg, and 4 mg tablets and is taken once daily on an empty stomach, preferably in the morning.
Important: These alternatives are not simple substitutes. Each one has different dosing, pharmacokinetics, and monitoring requirements. Your transplant nephrologist must supervise any change in your immunosuppressant regimen.
Prograf contains the same active ingredient — Tacrolimus — but in an immediate-release formulation. It's taken twice daily (every 12 hours) instead of once daily. Prograf is available as a brand-name product and as affordable generic Tacrolimus capsules in 0.5 mg, 1 mg, and 5 mg strengths.
Key differences from Envarsus XR:
Prograf is the most common alternative when Envarsus XR is unavailable. However, your doctor will need to recalculate your dose and monitor your Tacrolimus blood levels closely during the transition.
Astagraf XL is another once-daily Tacrolimus formulation, but it comes as extended-release capsules rather than tablets. It was developed by Astellas Pharma and uses a different extended-release mechanism than Envarsus XR.
Key differences from Envarsus XR:
Because Astagraf XL and Envarsus XR use different release mechanisms, switching between them requires careful dose adjustment and blood level monitoring.
Cyclosporine is an older calcineurin inhibitor that was the standard of care before Tacrolimus. It works through a similar mechanism but is generally considered less potent — studies show higher rates of acute rejection with Cyclosporine compared to Tacrolimus (46% vs. 31%).
Key considerations:
Switching from Tacrolimus to Cyclosporine is a significant change and is typically only done when Tacrolimus is not tolerated or not available for an extended period.
Sirolimus is an mTOR inhibitor — a completely different class of immunosuppressant. It does not inhibit calcineurin and works by blocking a different pathway in T cell activation.
Key considerations:
Sirolimus is not a first-line alternative to Envarsus XR for most patients, but your transplant team may consider it in specific situations.
For more information on finding this medication, see our guide on how to find Envarsus XR in stock near you. You can also learn more about what Envarsus XR is and how it's used.
There are alternatives to Envarsus XR, but none of them are drop-in replacements. Every switch requires your transplant doctor's involvement, dose recalculation, and close blood level monitoring. The safest approach is always to find Envarsus XR itself — and tools like Medfinder make that easier.
If you do need to switch, your transplant team has done it before. Trust the process, keep communication open, and never skip doses on your own.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.